Induction therapy in renal transplantation
- 1 December 2001
- journal article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 6 (4) , 320-326
- https://doi.org/10.1097/00075200-200112000-00009
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantationNephrology Dialysis Transplantation, 2000
- LOW DOSE ANTITHYMOCYTE GLOBULINS IN RENAL TRANSPLANTATIONTransplantation, 2000
- The use of thymoglobuline induction in renal transplantation: a pharmacovigilance studyTransplantation Proceedings, 2000
- A RANDOMIZED, DOUBLE-BLINDED COMPARISON OF THYMOGLOBULIN VERSUS ATGAM FOR INDUCTION IMMUNOSUPPRESSIVE THERAPY IN ADULT RENAL TRANSPLANT RECIPIENTS1,2Transplantation, 1999
- Immediate and long-term results of ATG induction therapy for delayed graft function compared to conventional therapy for immediate graft functionTransplant International, 1999
- Effect of antithymocyte globulin induction treatment on renal transplant outcomeTransplantation Proceedings, 1998
- RESULTS OF THE DOUBLE-BLIND, RANDOMIZED, MULTICENTER, PHASE III CLINICAL TRIAL OF THYMOGLOBULIN VERSUS ATGAM IN THE TREATMENT OF ACUTE GRAFT REJECTION EPISODES AFTER RENAL TRANSPLANTATION1,2Transplantation, 1998
- Induction therapy with rabbit antithymocyte sera reduces rejection episodes in immunologically low-risk living donor renal transplant recipientsTransplantation Proceedings, 1997
- Effect of anti-lymphocyte induction therapy on renal allograft survivalJournal of the American Society of Nephrology, 1997
- REDUCED HUMAN IgG ANTI-ATGAM ANTIBODY FORMATION IN RENAL TRANSPLANT RECIPIENTS RECEIVING MYCOPHENOLATE MOFETIL1,2Transplantation, 1995